Induction of apoptosis in Eμ-myc lymphoma cells in vitro and in vivo through calpain inhibition

Experimental Hematology

Volumn 40, Issue 7, 2012, Pages

  Li, Hongbing ^a,b   Nepal, Rajeev M ^b   Martin, Alberto ^b   Berger, Stuart A ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPAIN 1; CALPAIN 2; CALPASTATIN; CASPASE 3; CASPASE 3 INHIBITOR; CASPASE 7 INHIBITOR; CASPASE 9; CASPASE 9 INHIBITOR; CASPASE INHIBITOR; CYSTEINE PROTEINASE INHIBITOR; ETOPOSIDE; MYC PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PD 150606; UNCLASSIFIED DRUG; [1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BURKITT LYMPHOMA; CANCER SIZE; CELL CYCLE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG POTENTIATION; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA CELL; MOUSE; NICK END LABELING; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL;

MUS;

EID: 84862798809     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.02.002     Document Type: Article

References (43)

1. Taub R., Kirsch I., Morton C., et al. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A 1982, 79:7837-7841.
2. Fleming W.H., Murphy P.R., Murphy L.J., et al. Human growth hormone induces and maintains c-myc gene expression in Nb2 lymphoma cells. Endocrinology 1985, 117:2547-2549.
3. Selvakumaran M., Liebermann D., Hoffman-Liebermann B. Myeloblastic leukemia cells conditionally blocked by myc-estrogen receptor chimeric transgenes for terminal differentiation coupled to growth arrest and apoptosis. Blood 1993, 81:2257-2262.
4. Gibson A.W., Cheng T., Johnston R.N. Apoptosis induced by c-myc overexpression is dependent on growth conditions. Exp Cell Res 1995, 218:351-358.
5. Hoffman B., Liebermann D.A., Selvakumaran M., Nguyen H.Q. Role of c-myc in myeloid differentiation, growth arrest and apoptosis. Curr Top Microbiol Immunol 1996, 211:17-27.
6. Dang C.V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 1999, 19:1-11.
7. Li Z., Van Calcar S., Qu C., Cavenee W.K., Zhang M.Q., Ren B. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci U S A 2003, 100:8164-8169.
8. Adams J.M., Harris A.W., Pinkert C.A., et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985, 318:533-538.
9. Alexander W.S., Bernard O., Langdon W.Y., et al. Oncogene cooperation and B-lymphoid tumorigenesis in Emu-myc transgenic mice. Haematol Blood Transfus 1989, 32:423-427.
10. Huang Y., Wang K.K. The calpain family and human disease. Trends Mol Med 2001, 7:355-362.
11. Goll D.E., Thompson V.F., Li H., Wei W., Cong J. The calpain system. Physiol Rev 2003, 83:731-801.
12. Yoshida H., Murachi T., Tsukahara I. Age-related changes of calpain II and alpha-crystallin in the lens of hereditary cataract (Nakano) mouse. Curr Eye Res 1985, 4:983-988.
13. Nilssone E., Alafuzoff I., Blennow K., et al. Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue. Neurobiol Aging 1990, 11:425-431.
14. Richard I., Broux O., Allamand V., et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995, 81:27-40.
15. Horikawa Y., Oda N., Cox N.J., et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000, 26:163-175.
16. Yoshikawa Y., Mukai H., Hino F., Asada K., Kato I. Isolation of two novel genes, down-regulated in gastric cancer. Jpn J Cancer Res 2000, 91:459-463.
17. Nath R., Raser K.J., McGinnis K., Nadimpalli R., Stafford D., Wang K.K. Effects of ICE-like protease and calpain inhibitors on neuronal apoptosis. Neuroreport 1996, 8:249-255.
18. Squier M.K., Cohen J.J. Calpain, an upstream regulator of thymocyte apoptosis. J Immunol 1997, 158:3690-3697.
19. Squier M.K., Sehnert A.J., Sellins K.S., et al. Calpain and calpastatin regulate neutrophil apoptosis. J Cell Physiol 1999, 178:311-319.
20. Cheng G., Shan J., Xu G., et al. Apoptosis induced by simvastatin in rat vascular smooth muscle cell through Ca2+-calpain and caspase-3 dependent pathway. Pharmacol Res 2003, 48:571-578.
21. Liu L., Xing D., Chen W.R., et al. Calpain-mediated pathway dominates cisplatin-induced apoptosis in human lung adenocarcinoma cells as determined by real-time single cell analysis. Int J Cancer 2008, 122:2210-2222.
22. Lu Q., Mellgren R.L. Calpain inhibitors and serine protease inhibitors can produce apoptosis in HL-60 cells. Arch Biochem Biophys 1996, 334:175-181.
23. Zhu D.M., Uckun F.M. Calpain inhibitor II induces caspase-dependent apoptosis in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells as well as some solid tumor cells. Clin Cancer Res 2000, 6:2456-2463.
24. Guan N., Korukonda R., Hurh E., Schmittgen T.D., Donkor I.O., Dalton J.T. Apoptosis induced by novel aldehyde calpain inhibitors in human tumor cell lines. Int J Oncol 2006, 29:655-663.
25. Mlynarczuk-Bialy I., Roeckmann H., Kuckelkorn U., et al. Combined effect of proteasome and calpain inhibition on cisplatin-resistant human melanoma cells. Cancer Res 2006, 66:7598-7605.
26. Cheng Y., Qiu F., Huang J., Tashiro S., Onodera S., Ikejima T. Apoptosis-suppressing and autophagy-promoting effects of calpain on oridonin-induced L929 cell death. Arch Biochem Biophys 2008, 475:148-155.
27. Niapour M., Yu Y., Berger S.A. Regulation of calpain activity by c-Myc through calpastatin and promotion of transformation in c-Myc-negative cells by calpastatin suppression. J Biol Chem 2008, 283:21371-21381.
28. Bertoli C., Copetti T., Lam E.W., Demarchi F., Schneider C. Calpain small-1 modulates Akt/FoxO3A signaling and apoptosis through PP2A. Oncogene 2009, 28:721-733.
29. Carragher N.O., Fonseca B.D., Frame M.C. Calpain activity is generally elevated during transformation but has oncogene-specific biological functions. Neoplasia 2004, 6:53-73.
30. Nepal R.M., Zaheen A., Basit W., Li L., Berger S.A., Martin A. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice. Oncogene 2008, 27:4752-4756.
31. Niapour M., Berger S. Flow cytometric measurement of calpain activity in living cells. Cytometry A 2007, 71:475-485.
32. Farr C., Berger S. Measuring calpain activity in fixed and living cells by flow cytometry. J Vis Exp 2010, 8(41).
33. Wang K.K., Nath R., Posner A., et al. An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. Proc Natl Acad Sci U S A 1996, 93:6687-6692.
34. Bast R.C.J., De Fabritiis P., Lipton J., et al. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Cancer Res 1985, 45:499-503.
35. Wang K.K., Posner A., Raser K.J., et al. Alpha-mercaptoacrylic acid derivatives as novel selective calpain inhibitors. Adv Exp Med Biol 1996, 389:95-101.
36. Schonn I., Hennesen J., Dartsch D.C. Cellular responses to etoposide: cell death despite cell cycle arrest and repair of DNA damage. Apoptosis 2010, 15:162-172.
37. Nicholson D.W., Ali A., Thornberry N.A., et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995, 376:37-43.
38. Roy S., Bayly C.I., Gareau Y., et al. Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide. Proc Natl Acad Sci U S A 2001, 98:6132-6137.
39. Albee L., Shi B., Perlman H. Aspartic protease and caspase 3/7 activation are central for macrophage apoptosis following infection with Escherichia coli. J Leukoc Biol 2007, 81:229-237.
40. Han Z., Hendrickson E.A., Bremner T.A., Wyche J.H. A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro. J Biol Chem 1997, 272:13432-13436.
41. Janossy J., Ubezio P., Apati A., Magocsi M., Tompa P., Friedrich P. Calpain as a multi-site regulator of cell cycle. Biochem Pharmacol 2004, 67:1513-1521.
42. Atencio I.A., Ramachandra M., Shabram P., Demers G.W. Calpain inhibitor 1 activates p53-dependent apoptosis in tumor cell lines. Cell Growth Differ 2000, 11:247-253.
43. Lwin T., Hazlehurst L.A., Li Z., et al. Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells. Leukemia 2007, 21:1521-1531.